nodes	percent_of_prediction	percent_of_DWPC	metapath
Dapagliflozin—UGT2B4—Farnesoid X Receptor  Pathway—ABCB4—sclerosing cholangitis	0.197	0.197	CbGpPWpGaD
Dapagliflozin—SLC5A11—NRF2 pathway—GGT1—sclerosing cholangitis	0.037	0.037	CbGpPWpGaD
Dapagliflozin—SLC5A11—Transmembrane transport of small molecules—CFTR—sclerosing cholangitis	0.0361	0.0361	CbGpPWpGaD
Dapagliflozin—SLC5A4—NRF2 pathway—GGT1—sclerosing cholangitis	0.027	0.027	CbGpPWpGaD
Dapagliflozin—SLC5A4—Transmembrane transport of small molecules—CFTR—sclerosing cholangitis	0.0264	0.0264	CbGpPWpGaD
Dapagliflozin—ABCB1—ABC-family proteins mediated transport—CFTR—sclerosing cholangitis	0.0251	0.0251	CbGpPWpGaD
Dapagliflozin—UGT2B4—Phase II conjugation—GGT1—sclerosing cholangitis	0.0237	0.0237	CbGpPWpGaD
Dapagliflozin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB4—sclerosing cholangitis	0.021	0.021	CbGpPWpGaD
Dapagliflozin—CYP3A4—Farnesoid X Receptor  Pathway—ABCB4—sclerosing cholangitis	0.0206	0.0206	CbGpPWpGaD
Dapagliflozin—SLC5A1—NRF2 pathway—GGT1—sclerosing cholangitis	0.0204	0.0204	CbGpPWpGaD
Dapagliflozin—SLC5A2—NRF2 pathway—GGT1—sclerosing cholangitis	0.0204	0.0204	CbGpPWpGaD
Dapagliflozin—SLC5A2—Transmembrane transport of small molecules—CFTR—sclerosing cholangitis	0.02	0.02	CbGpPWpGaD
Dapagliflozin—SLC5A1—Transmembrane transport of small molecules—CFTR—sclerosing cholangitis	0.02	0.02	CbGpPWpGaD
Dapagliflozin—SLC5A4—Carbohydrate metabolism—GOT2—sclerosing cholangitis	0.0198	0.0198	CbGpPWpGaD
Dapagliflozin—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB4—sclerosing cholangitis	0.0196	0.0196	CbGpPWpGaD
Dapagliflozin—UGT1A9—PPARA activates gene expression—ABCB4—sclerosing cholangitis	0.0179	0.0179	CbGpPWpGaD
Dapagliflozin—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—ABCB4—sclerosing cholangitis	0.0175	0.0175	CbGpPWpGaD
Dapagliflozin—SLC5A4—Carbohydrate metabolism—GOT1—sclerosing cholangitis	0.0171	0.0171	CbGpPWpGaD
Dapagliflozin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB4—sclerosing cholangitis	0.0167	0.0167	CbGpPWpGaD
Dapagliflozin—SLC5A2—Carbohydrate metabolism—GOT2—sclerosing cholangitis	0.015	0.015	CbGpPWpGaD
Dapagliflozin—SLC5A1—Carbohydrate metabolism—GOT2—sclerosing cholangitis	0.015	0.015	CbGpPWpGaD
Dapagliflozin—UGT2B4—Biological oxidations—GGT1—sclerosing cholangitis	0.0138	0.0138	CbGpPWpGaD
Dapagliflozin—SLC5A1—Carbohydrate metabolism—GOT1—sclerosing cholangitis	0.0129	0.0129	CbGpPWpGaD
Dapagliflozin—SLC5A2—Carbohydrate metabolism—GOT1—sclerosing cholangitis	0.0129	0.0129	CbGpPWpGaD
Dapagliflozin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB4—sclerosing cholangitis	0.0129	0.0129	CbGpPWpGaD
Dapagliflozin—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—ABCB4—sclerosing cholangitis	0.012	0.012	CbGpPWpGaD
Dapagliflozin—CYP1A2—Aflatoxin activation and detoxification—GGT1—sclerosing cholangitis	0.0109	0.0109	CbGpPWpGaD
Dapagliflozin—UGT2B7—Phase II conjugation—GGT1—sclerosing cholangitis	0.0108	0.0108	CbGpPWpGaD
Dapagliflozin—CYP1A1—PPARA activates gene expression—ABCB4—sclerosing cholangitis	0.0103	0.0103	CbGpPWpGaD
Dapagliflozin—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—ABCB4—sclerosing cholangitis	0.01	0.01	CbGpPWpGaD
Dapagliflozin—SLC5A4—Metabolism—ABCB4—sclerosing cholangitis	0.00987	0.00987	CbGpPWpGaD
Dapagliflozin—UGT1A9—Phase II conjugation—GGT1—sclerosing cholangitis	0.00876	0.00876	CbGpPWpGaD
Dapagliflozin—CYP3A4—Aflatoxin activation and detoxification—GGT1—sclerosing cholangitis	0.00844	0.00844	CbGpPWpGaD
Dapagliflozin—CYP1A1—Arachidonic acid metabolism—GGT1—sclerosing cholangitis	0.00791	0.00791	CbGpPWpGaD
Dapagliflozin—SLC5A1—Metabolism—ABCB4—sclerosing cholangitis	0.00748	0.00748	CbGpPWpGaD
Dapagliflozin—SLC5A2—Metabolism—ABCB4—sclerosing cholangitis	0.00748	0.00748	CbGpPWpGaD
Dapagliflozin—UGT2B7—NRF2 pathway—GGT1—sclerosing cholangitis	0.00719	0.00719	CbGpPWpGaD
Dapagliflozin—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—ABCB4—sclerosing cholangitis	0.00692	0.00692	CbGpPWpGaD
Dapagliflozin—UGT2B7—Biological oxidations—GGT1—sclerosing cholangitis	0.00631	0.00631	CbGpPWpGaD
Dapagliflozin—CYP2C9—Arachidonic acid metabolism—GGT1—sclerosing cholangitis	0.0059	0.0059	CbGpPWpGaD
Dapagliflozin—UGT1A9—NRF2 pathway—GGT1—sclerosing cholangitis	0.00584	0.00584	CbGpPWpGaD
Dapagliflozin—UGT2B4—Metabolism—ABCB4—sclerosing cholangitis	0.00577	0.00577	CbGpPWpGaD
Dapagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—MST1—sclerosing cholangitis	0.00561	0.00561	CbGpPWpGaD
Dapagliflozin—SLC5A4—Disease—GOT2—sclerosing cholangitis	0.0056	0.0056	CbGpPWpGaD
Dapagliflozin—UGT1A9—Biological oxidations—GGT1—sclerosing cholangitis	0.00512	0.00512	CbGpPWpGaD
Dapagliflozin—CYP1A2—Arachidonic acid metabolism—GGT1—sclerosing cholangitis	0.00504	0.00504	CbGpPWpGaD
Dapagliflozin—SLC5A4—Disease—GOT1—sclerosing cholangitis	0.00483	0.00483	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism of lipids and lipoproteins—ABCB4—sclerosing cholangitis	0.0048	0.0048	CbGpPWpGaD
Dapagliflozin—SLC5A4—Metabolism—GOT2—sclerosing cholangitis	0.00469	0.00469	CbGpPWpGaD
Dapagliflozin—CYP2A6—NRF2 pathway—GGT1—sclerosing cholangitis	0.0045	0.0045	CbGpPWpGaD
Dapagliflozin—SLC5A1—Disease—GOT2—sclerosing cholangitis	0.00424	0.00424	CbGpPWpGaD
Dapagliflozin—SLC5A2—Disease—GOT2—sclerosing cholangitis	0.00424	0.00424	CbGpPWpGaD
Dapagliflozin—SLC5A4—Metabolism—GGT1—sclerosing cholangitis	0.00405	0.00405	CbGpPWpGaD
Dapagliflozin—SLC5A4—Metabolism—GOT1—sclerosing cholangitis	0.00405	0.00405	CbGpPWpGaD
Dapagliflozin—CYP2A6—Biological oxidations—GGT1—sclerosing cholangitis	0.00395	0.00395	CbGpPWpGaD
Dapagliflozin—SLC5A1—Disease—GOT1—sclerosing cholangitis	0.00366	0.00366	CbGpPWpGaD
Dapagliflozin—SLC5A2—Disease—GOT1—sclerosing cholangitis	0.00366	0.00366	CbGpPWpGaD
Dapagliflozin—SLC5A1—Metabolism—GOT2—sclerosing cholangitis	0.00355	0.00355	CbGpPWpGaD
Dapagliflozin—SLC5A2—Metabolism—GOT2—sclerosing cholangitis	0.00355	0.00355	CbGpPWpGaD
Dapagliflozin—ABCB1—HIF-1-alpha transcription factor network—HIF1A—sclerosing cholangitis	0.00352	0.00352	CbGpPWpGaD
Dapagliflozin—SLC5A4—Disease—HIF1A—sclerosing cholangitis	0.00336	0.00336	CbGpPWpGaD
Dapagliflozin—CYP1A2—Phase II conjugation—GGT1—sclerosing cholangitis	0.00321	0.00321	CbGpPWpGaD
Dapagliflozin—ABCB1—HIF-1-alpha transcription factor network—NOS2—sclerosing cholangitis	0.0032	0.0032	CbGpPWpGaD
Dapagliflozin—SLC5A2—Metabolism—GGT1—sclerosing cholangitis	0.00307	0.00307	CbGpPWpGaD
Dapagliflozin—SLC5A1—Metabolism—GOT1—sclerosing cholangitis	0.00307	0.00307	CbGpPWpGaD
Dapagliflozin—SLC5A2—Metabolism—GOT1—sclerosing cholangitis	0.00307	0.00307	CbGpPWpGaD
Dapagliflozin—SLC5A1—Metabolism—GGT1—sclerosing cholangitis	0.00307	0.00307	CbGpPWpGaD
Dapagliflozin—SLC5A4—Disease—NOS2—sclerosing cholangitis	0.00306	0.00306	CbGpPWpGaD
Dapagliflozin—CYP1A1—Biological oxidations—GGT1—sclerosing cholangitis	0.00294	0.00294	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism of lipids and lipoproteins—ABCB4—sclerosing cholangitis	0.00276	0.00276	CbGpPWpGaD
Dapagliflozin—UGT2B4—Metabolism—GOT2—sclerosing cholangitis	0.00274	0.00274	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—ABCB4—sclerosing cholangitis	0.00263	0.00263	CbGpPWpGaD
Dapagliflozin—ABCB1—Transmembrane transport of small molecules—CFTR—sclerosing cholangitis	0.00262	0.00262	CbGpPWpGaD
Dapagliflozin—SLC5A1—Disease—HIF1A—sclerosing cholangitis	0.00255	0.00255	CbGpPWpGaD
Dapagliflozin—SLC5A2—Disease—HIF1A—sclerosing cholangitis	0.00255	0.00255	CbGpPWpGaD
Dapagliflozin—UGT2B4—Metabolism—GGT1—sclerosing cholangitis	0.00237	0.00237	CbGpPWpGaD
Dapagliflozin—UGT2B4—Metabolism—GOT1—sclerosing cholangitis	0.00237	0.00237	CbGpPWpGaD
Dapagliflozin—SLC5A1—Disease—NOS2—sclerosing cholangitis	0.00232	0.00232	CbGpPWpGaD
Dapagliflozin—SLC5A2—Disease—NOS2—sclerosing cholangitis	0.00232	0.00232	CbGpPWpGaD
Dapagliflozin—CYP2D6—Biological oxidations—GGT1—sclerosing cholangitis	0.00222	0.00222	CbGpPWpGaD
Dapagliflozin—CYP2C9—Biological oxidations—GGT1—sclerosing cholangitis	0.0022	0.0022	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—ABCB4—sclerosing cholangitis	0.00214	0.00214	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism of lipids and lipoproteins—ABCB4—sclerosing cholangitis	0.00206	0.00206	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism of lipids and lipoproteins—GGT1—sclerosing cholangitis	0.00197	0.00197	CbGpPWpGaD
Dapagliflozin—CYP1A2—Biological oxidations—GGT1—sclerosing cholangitis	0.00188	0.00188	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism of lipids and lipoproteins—ABCB4—sclerosing cholangitis	0.00176	0.00176	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—ABCB4—sclerosing cholangitis	0.00165	0.00165	CbGpPWpGaD
Dapagliflozin—CYP3A4—Biological oxidations—GGT1—sclerosing cholangitis	0.00145	0.00145	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—GOT2—sclerosing cholangitis	0.00125	0.00125	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—ABCB4—sclerosing cholangitis	0.00123	0.00123	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism of lipids and lipoproteins—GGT1—sclerosing cholangitis	0.00113	0.00113	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—GOT1—sclerosing cholangitis	0.00108	0.00108	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—GGT1—sclerosing cholangitis	0.00108	0.00108	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—GOT2—sclerosing cholangitis	0.00102	0.00102	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—ABCB4—sclerosing cholangitis	0.00098	0.00098	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—ABCB4—sclerosing cholangitis	0.000924	0.000924	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—ABCB4—sclerosing cholangitis	0.000916	0.000916	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—GGT1—sclerosing cholangitis	0.000876	0.000876	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—GOT1—sclerosing cholangitis	0.000876	0.000876	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—sclerosing cholangitis	0.000843	0.000843	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—ABCB4—sclerosing cholangitis	0.000783	0.000783	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—GOT2—sclerosing cholangitis	0.000783	0.000783	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism of lipids and lipoproteins—GGT1—sclerosing cholangitis	0.000721	0.000721	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—GGT1—sclerosing cholangitis	0.000676	0.000676	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—GOT1—sclerosing cholangitis	0.000676	0.000676	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—ABCB4—sclerosing cholangitis	0.000604	0.000604	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—GOT2—sclerosing cholangitis	0.000583	0.000583	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—GGT1—sclerosing cholangitis	0.000503	0.000503	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—GOT1—sclerosing cholangitis	0.000503	0.000503	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—GOT2—sclerosing cholangitis	0.000466	0.000466	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—GOT2—sclerosing cholangitis	0.000439	0.000439	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—GOT2—sclerosing cholangitis	0.000435	0.000435	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—GGT1—sclerosing cholangitis	0.000402	0.000402	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—GOT1—sclerosing cholangitis	0.000402	0.000402	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—GGT1—sclerosing cholangitis	0.000379	0.000379	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—GOT1—sclerosing cholangitis	0.000379	0.000379	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—GOT1—sclerosing cholangitis	0.000376	0.000376	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—GGT1—sclerosing cholangitis	0.000376	0.000376	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—GOT2—sclerosing cholangitis	0.000372	0.000372	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—GGT1—sclerosing cholangitis	0.000321	0.000321	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—GOT1—sclerosing cholangitis	0.000321	0.000321	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—GOT2—sclerosing cholangitis	0.000287	0.000287	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—GGT1—sclerosing cholangitis	0.000248	0.000248	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—GOT1—sclerosing cholangitis	0.000248	0.000248	CbGpPWpGaD
